Isda AGM: US regulator identifies six weaknesses in OTC market

Rob Davies
23 Apr 2009

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

While praising the derivatives industry for the strides it has made in improving operations infrastructure - specifically, the reduction in backlogs and improvements in novations processing - Lubke said there is still an over-reliance on manual processes. "There are still a lot of improvements needed to automate the market in a strong and efficient manner," he remarked.

The second area of concern for regulators, Lubke added, was what he referred to as "structural design weaknesses in how

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]